TRIM22 in cancer: a context-dependent E3 ligase at the interface of interferon, p53, and tumor plasticity
TRIM22 is a TRIM family E3 ubiquitin ligase whose expression is strongly induced by interferons. For many years, it has been identified primarily as an antiviral effector, a role that remains well validated. A growing body of cancer-related work now forces us to expand that view considerably. Depending on tumor type, u...